Current and historical gross margin, operating margin and net profit margin for 10x Genomics (TXG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. 10x Genomics net profit margin as of June 30, 2024 is -37.9%.
| 10x Genomics Annual Profit Margins |
|---|
| 10x Genomics Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.695B | $0.619B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.689B | 21.35 |
| Tempus AI (TEM) | United States | $7.620B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.083B | 1133.28 |
| Hims & Hers Health (HIMS) | United States | $3.559B | 207.12 |
| Axonics (AXNX) | United States | $3.518B | 0.00 |
| Enovis (ENOV) | United States | $2.421B | 17.55 |
| IRhythm Technologies (IRTC) | United States | $2.393B | 0.00 |
| Azenta (AZTA) | United States | $2.373B | 134.78 |
| Privia Health (PRVA) | United States | $2.266B | 157.92 |
| Omnicell (OMCL) | United States | $1.985B | 65.39 |
| Schrodinger (SDGR) | United States | $1.509B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.487B | 0.00 |
| Phreesia (PHR) | United States | $1.426B | 0.00 |
| Standard BioTools (LAB) | United States | $0.765B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.677B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.524B | 444.00 |
| Health Catalyst (HCAT) | United States | $0.510B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.408B | 0.00 |
| Talkspace (TALK) | United States | $0.330B | 0.00 |
| Pulmonx (LUNG) | United States | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.262B | 0.00 |
| TruBridge (TBRG) | United States | $0.184B | 13.48 |
| P3 Health Partners (PIII) | United States | $0.176B | 0.00 |
| American Well (AMWL) | United States | $0.140B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.056B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Outset Medical (OM) | United States | $0.028B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.025B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |
